BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 19799147)

  • 1. [Study on E protein epitopes and primary identification of main yellow virus].
    Xu XL; Yang JJ; Ren RW; Liu JW; Ma SB; Bai ZJ; Fang MY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 May; 30(5):489-92. PubMed ID: 19799147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Screening and identification of dengue virus type 2-specific antigens].
    Ren R; Tang B; Zhang P; Hu W; Hong W; Liu J
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Nov; 32(11):1667-70. PubMed ID: 23174601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface expression of an immunodominant malaria protein B cell epitope by yellow fever virus.
    Bonaldo MC; Garratt RC; Caufour PS; Freire MS; Rodrigues MM; Nussenzweig RS; Galler R
    J Mol Biol; 2002 Jan; 315(4):873-85. PubMed ID: 11812154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of Japanese encephalitis virus envelope protein gene from swine.
    Fan JM; Luo J; Zhang GP; Chen L; Teng M; Yang MF; Wang L; Wang CQ
    Lett Appl Microbiol; 2010 Jul; 51(1):11-7. PubMed ID: 20477964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of dengue complex-reactive epitopes on dengue 3 virus envelope protein domain III.
    Matsui K; Gromowski GD; Li L; Schuh AJ; Lee JC; Barrett AD
    Virology; 2009 Feb; 384(1):16-20. PubMed ID: 19101005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standardized quantitative RT-PCR assays for quantitation of yellow fever and chimeric yellow fever-dengue vaccines.
    Mantel N; Aguirre M; Gulia S; Girerd-Chambaz Y; Colombani S; Moste C; Barban V
    J Virol Methods; 2008 Jul; 151(1):40-6. PubMed ID: 18501437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus.
    Gromowski GD; Barrett AD
    Virology; 2007 Sep; 366(2):349-60. PubMed ID: 17719070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The cloning and sequence analysis of cDNA of the partial E genomic region of Dengue type 4 virus from a Chinese patient].
    Li G; Yao J; Peng W; Wang F
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Mar; 11(1):62-5. PubMed ID: 15619909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The identification of immunodominant linear epitopes of dengue type 2 virus capsid and NS4a proteins using pin-bound peptides.
    Anandarao R; Swaminathan S; Khanna N
    Virus Res; 2005 Sep; 112(1-2):60-8. PubMed ID: 16022901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of the E gene sequences of three dengue virus type 1 isolates in Guangdong province].
    Tian XD; Liu JW; Fang MY; Jiang LH; Ren RW; Hong WY; Cheng GF
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Jan; 25(1):54-7. PubMed ID: 15683998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis.
    Guirakhoo F; Zhang ZX; Chambers TJ; Delagrave S; Arroyo J; Barrett AD; Monath TP
    Virology; 1999 May; 257(2):363-72. PubMed ID: 10329547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of dengue 2 envelope domain III in plant using TMV-based vector system.
    Saejung W; Fujiyama K; Takasaki T; Ito M; Hori K; Malasit P; Watanabe Y; Kurane I; Seki T
    Vaccine; 2007 Sep; 25(36):6646-54. PubMed ID: 17659815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica.
    Roehrig JT; Bolin RA; Kelly RG
    Virology; 1998 Jul; 246(2):317-28. PubMed ID: 9657950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and purification of an immunogenic dengue virus epitope using a synthetic consensus sequence of envelope domain III and Saccharomyces cerevisiae.
    Nguyen NL; Kim JM; Park JA; Park SM; Jang YS; Yang MS; Kim DH
    Protein Expr Purif; 2013 Apr; 88(2):235-42. PubMed ID: 23376461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fragment of Japanese encephalitis virus envelope protein produced in Escherichia coli protects mice from virus challenge.
    Chia SC; Leung PS; Liao CP; Huang JH; Lee ST
    Microb Pathog; 2001 Jul; 31(1):9-19. PubMed ID: 11427032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretion of noninfectious dengue virus-like particles and identification of amino acids in the stem region involved in intracellular retention of envelope protein.
    Purdy DE; Chang GJ
    Virology; 2005 Mar; 333(2):239-50. PubMed ID: 15721358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A custom-designed recombinant multiepitope protein as a dengue diagnostic reagent.
    AnandaRao R; Swaminathan S; Fernando S; Jana AM; Khanna N
    Protein Expr Purif; 2005 May; 41(1):136-47. PubMed ID: 15802231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of computer-predicted antibody inducing epitope on Japanese encephalitis virus.
    Kutubuddin M; Gore MM; Banerjee K; Ghosh SN; Kolaskar AS
    Acta Virol; 1993 Dec; 37(6):417-28. PubMed ID: 7516621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Western blot analysis of antigens specifically recognized by natural immune responses of patients with Japanese encephalitis infections.
    Patarapotikul J; Pothipunya S; Wanotayan R; Hongyantarachai A; Tharavanij S
    Southeast Asian J Trop Med Public Health; 1993 Jun; 24(2):269-76. PubMed ID: 8266229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning and expression of envelope protein of Thai genotype I strain KE-093 of Japanese encephalitis virus.
    Witthajitsomboon N; Chen A; Lorroengsil S; Sällberg M; Pantuwatana S
    Southeast Asian J Trop Med Public Health; 2010 Nov; 41(6):1359-67. PubMed ID: 21329311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.